UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007270
Receipt number R000008577
Scientific Title Preventive effect of frozen glove for paclitaxel -induced peripheral neurotoxicity in patients with breast cancer
Date of disclosure of the study information 2012/02/13
Last modified on 2012/02/12 18:08:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preventive effect of frozen glove for paclitaxel -induced peripheral neurotoxicity in patients with breast cancer

Acronym

Preventive effect of frozen glove for paclitaxel -induced peripheral neurotoxicity in patients with breast cancer

Scientific Title

Preventive effect of frozen glove for paclitaxel -induced peripheral neurotoxicity in patients with breast cancer

Scientific Title:Acronym

Preventive effect of frozen glove for paclitaxel -induced peripheral neurotoxicity in patients with breast cancer

Region

Japan


Condition

Condition

Breast Cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Analysis of preventive effect of frozen glove for paclitaxel -induced peripheral neurotoxicity

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Occurrence of paclitaxel -induced peripheral neurotoxicity and preventive effect of frozen glove for paclitaxel -induced peripheral neurotoxicity

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1) Breast cancer patient who receiving paclitaxel
2) written informed consent


Key exclusion criteria

patients untolerable for cooling

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Suzuki Sachi

Organization

Wakayama Medical University Kihoku Hospital

Division name

Nursing Department

Zip code


Address

649-7113 279 Myoji, Kasturagicho, Ito, Wakayama, Japan

TEL

0736-22-0066

Email



Public contact

Name of contact person

1st name
Middle name
Last name Suzuki Sachi

Organization

Wakayama Medical University Kihoku Hospital

Division name

Nursing Department

Zip code


Address


TEL


Homepage URL


Email

yuzu-soushi2518@hb.tp1.jp


Sponsor or person

Institute

Wakayama Medical University Kihoku Hospital

Institute

Department

Personal name



Funding Source

Organization

Wakayama Medical University Kihoku Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 02 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2012 Year 02 Month 13 Day

Date of IRB


Anticipated trial start date

2012 Year 02 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2012 Year 02 Month 12 Day

Last modified on

2012 Year 02 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008577


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name